1. Home
  2. TPCS vs CELU Comparison

TPCS vs CELU Comparison

Compare TPCS & CELU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo TechPrecision Corporation

TPCS

TechPrecision Corporation

HOLD

Current Price

$3.48

Market Cap

39.4M

Sector

Industrials

ML Signal

HOLD

Logo Celularity Inc.

CELU

Celularity Inc.

HOLD

Current Price

$0.74

Market Cap

35.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TPCS
CELU
Founded
1956
2016
Country
United States
United States
Employees
N/A
123
Industry
Metal Fabrications
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
39.4M
35.2M
IPO Year
2008
N/A

Fundamental Metrics

Financial Performance
Metric
TPCS
CELU
Price
$3.48
$0.74
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$6.00
AVG Volume (30 Days)
23.6K
143.9K
Earning Date
02-17-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
64.20
N/A
EPS
N/A
N/A
Revenue
$34,031,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$76.00
P/E Ratio
N/A
N/A
Revenue Growth
7.72
N/A
52 Week Low
$2.88
$0.67
52 Week High
$6.25
$4.35

Technical Indicators

Market Signals
Indicator
TPCS
CELU
Relative Strength Index (RSI) 32.22 38.28
Support Level $3.40 $0.69
Resistance Level $4.01 $1.43
Average True Range (ATR) 0.15 0.11
MACD -0.05 -0.01
Stochastic Oscillator 7.50 16.67

Price Performance

Historical Comparison
TPCS
CELU

About TPCS TechPrecision Corporation

Techprecision Corp manufactures metal fabricated and machined precision components and systems. It offers a full range of services required to transform raw materials into precision finished products. The company's products are used in markets including defense, aerospace, nuclear, medical, and precision industries. All of its operations and customers are located in the United States. The company have two wholly owned subsidiaries that are each reportable segments: Ranor and Stadco. Each reportable segment focuses on the manufacture and assembly of specific components. It derives maximum revenue from Ranor segment.

About CELU Celularity Inc.

Celularity Inc is a clinical-stage biotechnology company developing off-the-shelf placental-derived allogeneic cell therapies including genetically modified and unmodified NK cells, engineered T cells including CAR-T cells, and mesenchymal-like adherent stromal cells, targeting indications across cancer, immunologic, infectious, and degenerative diseases. It manages its operations through an evaluation of three distinct business segments which include Cell Therapy, Degenerative Disease, and bio-banking. The company generates the majority of its revenue from the bio-banking segment.

Share on Social Networks: